ECG Neural Network Screening for Congenital Long QT Syndrome

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods struggle to accurately distinguish between congenital long QT syndrome (LQTS) and acquired QT prolongation, which is crucial for timely and appropriate management, as LQTS is potentially lethal yet highly treatable.

Innovation Solution

A neural network-based system using electrocardiogram (ECG) data is trained to differentiate between LQTS and acquired QT prolongation by employing a convolutional neural network with 2D stacked blocks and a final output layer activated by an activation function, utilizing ECG data from subjects with known LQTS status for training.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional ECG analysis methods are used to identify QT prolongation, then the detection process is simple and quick, but the accuracy in distinguishing LQTS from acquired QT prolongation is insufficient

Engineering Contradiction:
Improvediagnosis accuracyVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces traditional mechanical/manual ECG analysis methods with an artificial intelligence-based automated system. The neural network model processes ECG signals to automatically distinguish LQTS from acquired QT prolongation, substituting human expert analysis with computational intelligence to achieve higher diagnostic accuracy without manual intervention

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces an AI-based intermediary system that acts as a mediator between raw ECG data and clinical diagnosis. The neural network serves as an intermediate processing layer that extracts subtle patterns and features from ECG signals, translating complex electrical heart activity into actionable diagnostic information about LQTS versus acquired QT prolongation

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If AI-based methods are used to distinguish LQTS from acquired QT prolongation, then diagnostic accuracy is improved, but the computational complexity and processing time increase

Engineering Contradiction:
Improvediagnosis accuracyVSAvoidprocessing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent applies preliminary action by pre-training the neural network model on extensive datasets of ECG patterns from both LQTS and acquired QT prolongation cases. This pre-training phase allows the system to learn and store diagnostic patterns in advance, enabling rapid inference and classification when actual patient data is input, thus reducing real-time processing time while maintaining high accuracy

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent optimizes model parameters and architecture to balance accuracy and processing speed. By adjusting hyperparameters, network depth, and computational resources allocated to different processing stages, the system achieves high diagnostic accuracy (AUC 0.896) while minimizing processing time, making the AI-based approach clinically viable

Inventive Principle:
Principle #35Parameter changes

3Reliability

If comprehensive ECG analysis is performed to differentiate LQTS, then diagnostic reliability is improved, but the risk of false positives from acquired QT prolongation increases

Engineering Contradiction:
Improvediagnostic reliabilityVSAvoidfalse positive rate
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by training the neural network to recognize specific localized patterns and features that are characteristic of LQTS versus acquired QT prolongation. Rather than treating all QT prolongation uniformly, the model learns to identify subtle local differences in ECG waveforms, intervals, and morphological features that distinguish congenital from acquired causes, thereby improving diagnostic reliability while reducing false positives

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS12524672B2System, method, and apparatus for identifying congenital long QT syndrome in a subject
Publication Date: 2026.01.13 MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH
  • US12524672B2 patent drawing
  • US12524672B2 patent drawing
  • US12524672B2 patent drawing

AI summary

Described herein are systems, methods, and apparatuses for identifying LQTS in a subject. A system may include an electrocardiogram (ECG) sensor configured to detect an ECG datum. A system may include a computing device configured to receive an electrocardiogram (ECG) datum; train an LQTS determination machine learning model on a training dataset including a plurality of example ECG data as inputs correlated to a plurality of example LQTS data as outputs; and generate an LQTS determination datum as a function of the ECG datum using the trained LQTS determination machine learning model. A system may include a display configured to display an LQTS determination datum.